| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |